Epidemiology of herpes zoster infection among patients treated in primary care centres in the valencian community (Spain)

BMC Family Practice

Volumn 11, Issue , 2010, Pages

  Cebrin Cuenca, Ana M ^a   Díez Domingo, Javier ^b   Rodríguez, María San Martín ^c   Puig Barber, Joan ^a   Navarro Pérez, Jorge ^d  

^a Centro de Salud Nazaret   (Spain)

^b Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

^c AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HERPES ZOSTER; HUMAN; INCIDENCE; MALE; MIDDLE AGED; POPULATION; PRIMARY HEALTH CARE; SPAIN;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; HERPES ZOSTER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION; PRIMARY HEALTH CARE; SPAIN; YOUNG ADULT;

EID: 77951867454     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-11-33     Document Type: Article

References (34)

1. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. SL Thomas JG Wheeler AJ Hall, Lancet 2002 360 678 682
2. Neuralgia postherpética: incidencia, prevencián y tratamiento. D Ly Pen L Manzano Espinosa, Rev Clin Esp 2007 207 23 28
3. Herpes zoster in older adults. K Schmader, Clin Infect Dis 2001 32 1481 1486
4. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. MN Oxman MJ Levin GR Johnson KE Schmader SE Straus LD Gelb RD Arbeit MS Simberkoff AA Gershon LE Davis A Weinberg KD Boardmand HM Williams J Hongyuan Zhang PN Peduzzi CE Beisel VA Morrison JC Guatelli PA Brooks CA Kauffman CT Pachucki KM Neuzil RF Betts PF Wright MR Griffin P Brunell NE Soto AR Marques SK Keay RP Goodman DJ Cotton JW Gnann Jr J Loutit M Holodniy WA Keitel GE Crawford SS Yeh Z Lobo JF Toney RN Greenberg PM Keller R Harbecke AR Hayward MR Irwin TC Kyriakides CY Chan ISF Chan WWB Wang PW Annunziato JL Silber for the Shingles Prevention Study Group, N Engl J Med 2005 352 2271 2284
5. Modelling the impact of immunization on the epidemiology of varicella zoster virus. M Brisson WJ Edmunds NJ Gay B Law G De Serres, Epidemiol Infect 2002 125 651 669
6. What does epidemiology tell us about risk factors for herpes zoster? SL Thomas AJ Hall, Lancet Infect Dis 2004 4 26 33
7. The nature of Herpes Zoster: a long-term study and a new hypothesis. RE Hope-Simpson, Proc R Soc Med 1965 58 9 20
8. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. WK Yih DR Brooks SM Lett AO Jumaan Z Zhang KM Clements JF Seward, BMC Public Health 2005 5 68 77
9. The epidemiology of varicella and herpes zoster in The Netherlands: Implications for varicella zoster virus vaccination. H De Melker G Berbers S Hahné H Rümke S van den Hof A De Wit H Boot, Vaccine 2006 24 3946 3952
10. Incidence of herpes zoster, before and after varicella-vaccination- associated decreases in the incidence of varicella, 1992-2002. AO Jumaan O Yu LA Jackson K Bohlke K Galil JF Seward, J Infect Dis 2005 19 2002 2007
11. Incidence of herpes zoster, 1997-2002. JP Mullooly K Riedlinger C Chun S Weinmann H Houston, Epidemiol Infect 2005 133 245 253
12. Herpes Zoster. JW Gnann Jr RJ Whitley, N Engl J Med 2002 347 340 346
13. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. BP Yawn P Saddier PC Wollan JL St. Sauver MJ Kurland L Sy, Mayo Clin Proc 2007 82 1341 1349
14. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. JG Donahue BA Kieke PM Gargiullo AO Jumaan NR Berger JS Mc Cauley EA Belongia, Am J Public Health 2010
15. Impact of varicella vaccine on virus varicella zoster dynamics. S Schmid AO Jumaan, Clin Microbiol Rev 2010 23 1 202 217
16. Spanish National Statistics Institute, http://www.ine.es/jaxi/tabla.do? path=/t20/e245/p04/a2007/l0/&file=00000003.px&type=pcaxis&L=0
17. Development of a mesure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. PM Coplan K Schmader A Nikas IS Chan P Choo MJ Levin G Johnson M Bauer HM Williams KM Kaplan HA Guess MN Oxman, J Pain 2004 5 344 356
18. Incidencia de la varicela y el herpes zoster antes de la introduccián de la vacunacián sistemtica infantil en Navarra, 2005-2006. M García Cenoz J Castilla Y Montes J Morn A Salaberri F Elía Y Floristn I Rodrigo F Irisarri M Arriazu A Zabala A Barricarte, An Sist Sanit Navar 2008 31 71 80
19. Varicella and Herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004. N Pérez-Farinás M Ordobs C García-Frenndez L García-Comas S Cãellas I Rodero A Gutiérrez-Rodríguez J García-Gutiérrez R Ramírez, BMC Infect Dis 2007 7 59
20. The incidence of Herpes Zoster in a United States Administrative Database. R Insinga RF Itzler JM Pellissier P Saddier AA Nikas, J Gen Intern Med 2005 20 748 753
21. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. A Gautier J Breuer D Carrington M Martin V Rèmy, Epidemiol Infect 2009 137 38 47
22. Characteristics of patients with herpes zoster on presentation to practitioners in France. Ch Chidiac J Bruxelle JP Daures T Hoang Xuan P Morel A Leplège A El Hasnaoui C de Labareyre, Clin Infect Dis 2001 33 62 69
23. Gender as independent risk factor for herpes zoster: a population based study. W Opstelten GA Van Essen F Schellevis T Verheij K Moons, Ann Epidemiol 2006 16 692 695
24. The burden of Herpes Zoster: A prospective population based study. FT Scott RW Johnson M Leedham-Green E Davies WJ Edmunds J Breuer, Vaccine 2006 24 1308 1314
25. Epidemiology of varicella zoster virus infection in Canada and in the United Kingdom. M Brisson WJ Edmunds B Law NJ Gay R Walld M Brownell L Roos G De Serres, Epidemiol Infect 2001 127 305 314
26. The incidence of herpes zoster. JG Donahue PW Choo JE Manson R Platt, Arch Intern Med 1995 155 1605 1609
27. Population-based study of herpes zoster and its sequelae. MW Ragozzino LJ Melton III LT Kurland CP Chu HO Perry, Medicine 1982 61 310 316
28. Gender difference in the incidence of shingles. DM Fleming KW Cross WA Cobb RS Chapmna, Epidemiol Infect 2004 132 1 5
29. Cost of chickenpox in Canada: part I. Cost of uncomplicated cases. B Law C Fitzsimon L Ford-Jones N MacDonald P Dèry W Vaudry, Pediatrics 1999 104 1 6
30. The burden of uncomplicated cases of chickenpox in Israel. E Somekh I Dalal T Shohat GM Ginsberg O Romano, J Infect 2002 45 233 236 (Pubitemid 36104855)
31. Neuropathic pain and its assessment. G Cruccu A Tuini, Surg Oncol 2010
32. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? BS Alper PR Lewis, J Fam Pract 2000 49 255 264
33. Antiviral treatment for preventing postherpetic neuralgia. Q Li N Chen M Zhou D Zhou Q Zhang L He, Cochrane database systematic reviewers 2009 D006866
34. Recommendations for the management of herpes zoster. RH Dworkin RW Johnson J Breuer JW Gnann MJ Levin M Backonja RF Betts AA Gershon ML Haanpaa MW McKendrick TJ Nurmikko AL Oaklander MN Oxman D Pavan-Langston KL Petersen MC Rowbotham KE Schmader BR Stacey SK Tyring AJ Wijck van MS Wallace SW Wassilew RJ Whitley, Clin Infect Dis 2007 44 1 1 26